We're loaded this week! Do you know what the PDRP is? If not, you can't know how it's changing pharmaceutical selling. The effects of statins on heart disease. Alpharma gets some pain …
Pharma News 2_23
Ed Silverman over at Pharmalot features the story that came out in the Wall Street Journal this week, about Genentech's Lucentis competing with its sibling drug, Avastin, in the treatment of macular …
The demise of VitesseLearning
Canadian press release here (Vitesse had merged not long ago with Canadian provider Provinent). I had a high opinion of the original U.S.-based VitesseLearning team, and enjoy collaborating with …
“Pediatric” Viagra – life-saver!
Viagra, the sexual dysfunction drug marketed by Pfizer, returned to its original roots as a cardiovascular treatment recently, when a doctor in England used it to help a preemie gain enough lung …
Pharma News 2_16
Some encouraging growth signals - Elan plans to ramp up after its recent brush with near-death, and Daiichi Sankyo plans a major U.S. sales force expansion. Novartis takes the high road with genetic …
Pharma News 2_08
Storm clouds for GSK and Avandia - loss of bone density with use of this drug for diabetes? (My question - is there any evidence one way or another whether this is a class effect with TZDs, or is it …